ARID3C and ovarian carcinoma: While far less is known about ARID3C [47], RNA-Seq analyses recently identified it within a signaling complex consisting of protein tyrosine phosphatase receptor type R (PTPRR), α-catenin, β-catenin, and E-cadherin that form exclusively in ovarian cancer [48].